Effects of Dexmedetomidine During IRE Procedures for Solid Tumours

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Cancer of LiverCancer of Pancreas
Interventions
DRUG

Dexmedetomidine

"Dexmedetomidine 0.4 µg/kg/hr infusion (from the start of anaesthesia until the end of anaesthesia).~Anaesthesia induction: propofol 2 mg/kg, rocuronium 0.6 mg/kg iv, and fentanyl 2-3 mikrogram/kg.~Anaesthesia maintenance: sevoflurane and oxygen 50%, rocuronium 0.1-0.2 mg/kg iv, fentanyl 1 mikrogram/kg as required"

Trial Locations (1)

75185

Uppsala University Hospital, Uppsala

All Listed Sponsors
lead

Uppsala University Hospital

OTHER

NCT02044224 - Effects of Dexmedetomidine During IRE Procedures for Solid Tumours | Biotech Hunter | Biotech Hunter